GTM: Morgan Stanley Maintains Hold Rating on ZoomInfo

Morgan Stanley kept its hold rating on ZoomInfo Technologies (GTM) on May 19, 2026, but slashed its price target to $5 from $9. The ZoomInfo hold rating reflects caution about near-term momentum despite the company’s solid fundamentals. GTM trades at $3.81, down 2.8% on the day. Meyka AI rates GTM with a grade of B+, reflecting balanced growth potential against current headwinds.

Morgan Stanley Maintains ZoomInfo Hold Rating Amid Price Target Cut

Morgan Stanley’s decision to maintain its hold rating signals neither enthusiasm nor alarm about ZoomInfo’s near-term prospects. The analyst firm lowered its price target to $5 from $9, reflecting a 44% reduction in upside potential. This adjustment suggests Morgan Stanley sees limited catalysts for near-term appreciation.

The hold rating places GTM in a middle ground. With 10 sell ratings, 8 hold ratings, and just 1 buy rating among analysts, the consensus leans bearish. GTM stock trades below its 50-day average of $5.83 and well below its 200-day average of $8.76, confirming downward pressure.

ZoomInfo Financial Metrics Show Resilience Despite Stock Decline

ZoomInfo’s valuation metrics remain attractive relative to growth. The company trades at a PE ratio of 9.65x and a price-to-sales ratio of 0.89x, both below software sector averages. Free cash flow yield stands at 33.4%, indicating strong cash generation relative to market cap. Operating margins of 19.4% demonstrate pricing power and operational efficiency in its go-to-market intelligence platform.

The stock’s market cap of $1.12 billion reflects a steep 62.5% year-to-date decline. Revenue growth of 2.9% and net income growth of 3.3% show the business stabilizing, though not accelerating. EPS grew 3.9% year-over-year, suggesting profitability improvements despite revenue headwinds.

Technical Indicators Signal Oversold Conditions for GTM Stock

Technical analysis reveals extreme weakness in ZoomInfo’s price action. The RSI of 23.54 indicates oversold conditions, suggesting potential for a bounce. The stock has fallen from a 52-week high of $12.51 to a low of $3.76, a 70% decline. Volume remains elevated at 7.1 million shares, above the 10.7 million average, showing active selling pressure.

The ADX reading of 26.19 confirms a strong downtrend remains in place. Bollinger Bands show the stock trading near the lower band at $3.37, typical of capitulation moves. Williams %R at -98.23 and Stochastic %K at 3.38 both suggest maximum pessimism, which historically precedes reversals.

Meyka AI Grade and Analyst Consensus on ZoomInfo

Meyka AI rates GTM with a grade of B+, reflecting balanced fundamentals against current market sentiment. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating suggests the stock may offer value for patient investors, though near-term volatility remains likely.

Analyst consensus remains cautious with a score of 2.0 on a scale where 1 is strong buy and 5 is strong sell. The price target consensus has compressed significantly following Morgan Stanley’s cut. These grades are not guaranteed and we are not financial advisors.

Final Thoughts

Morgan Stanley’s maintained hold rating on ZoomInfo (GTM) reflects a balanced view of a company facing near-term headwinds despite solid fundamentals. The $5 price target cut signals caution, yet the stock’s oversold technical condition and attractive valuation metrics suggest potential opportunity for contrarian investors. With a B+ Meyka grade and improving profitability metrics, GTM may stabilize once market sentiment shifts. Investors should monitor upcoming earnings on August 3, 2026, for signs of revenue acceleration or margin expansion that could justify higher valuations.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.